Enliven Therapeutics, Inc.
ELVN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001672619
In the last 90 days, Enliven Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 214 institutions reported holding it in 13F filings for Q2 2026, worth $4.06B in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Enliven Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 8 filings
- 4 insiders, $11.8M in total
- Insiders trading
- 4
- Net value
- −$11.8M
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Enliven Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Hohl Benjamin | CHIEF FINANCIAL OFFICER | 38,000 | Sep 21, 2026 | 8 |
| Collins Helen Louise | CHIEF MEDICAL OFFICER | 25,000 | Sep 21, 2026 | 11 |
| Derynck Mika K | Director | 0 | Aug 6, 2026 | 2 |
| Kunkel Lori Anne | Director | 41,884 | Jul 8, 2026 | 4 |
| OrbiMed Advisors LLC | 10% Owner | 6,555,102Indirect | Jun 24, 2026 | 2 |
| OrbiMed Capital GP VII LLC | 10% Owner | 6,555,102Indirect | Jun 24, 2026 | 2 |
| OrbiMed Genesis GP LLC | 10% Owner | 6,555,102Indirect | Jun 24, 2026 | 2 |
| Heyman Richard A. | Director | 22,647Indirect | Feb 19, 2026 | 4 |
| Garland J. Scott | Director | – | Feb 17, 2026 | 2 |
| Gupta Rishi | Director | 7,663,349Indirect | Feb 17, 2026 | 1 |
| Bauer Jake | Director | 87,372 | Feb 17, 2026 | 1 |
| Ballal Rahul D. | Director | 22,341 | Feb 17, 2026 | 1 |
| Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | 18,750 | Feb 17, 2026 | 7 |
| Patel Anish | CHIEF OPERATING OFFICER | 20,000 | Feb 17, 2026 | 5 |
| Fair Richard A. | PRESIDENT AND CEO | – | Dec 12, 2025 | 1 |
| Kintz Samuel | PRESIDENT AND CEO | 890,392Indirect | Nov 19, 2025 | 2 |
| Phillips Andrew John | Director | – | Feb 10, 2025 | 0 |
| Schwab Andrew J. | 10% Owner | 635,341Indirect | Feb 16, 2024 | 0 |
| Parmar Kush | 10% Owner | 635,341Indirect | Feb 16, 2024 | 0 |
| 5AM Opportunities I, L.P. | 10% Owner | 635,341Indirect | Feb 16, 2024 | 0 |
| 5AM Ventures VI, L.P. | 10% Owner | 635,341Indirect | Feb 16, 2024 | 0 |
| 5AM Opportunities I (GP), LLC | 10% Owner | 635,341Indirect | Feb 16, 2024 | 0 |
| 5AM Partners VI, LLC | 10% Owner | 635,341Indirect | Feb 16, 2024 | 0 |
| RA Capital Healthcare Fund LP | Other: Former 10% owner | 2,122,465Indirect | Feb 27, 2023 | 0 |
| Ra Capital Management, L.P. | Other: Former 10% owner | 2,122,465Indirect | Feb 27, 2023 | 0 |
| Kolchinsky Peter | Other: Former 10% owner | 2,122,465Indirect | Feb 27, 2023 | 0 |
| Shah Rajeev M. | Other: Former 10% owner | 2,122,465Indirect | Feb 27, 2023 | 0 |
| Commodore Capital LP | 10% Owner | 1,448,640Indirect | Feb 27, 2023 | 0 |
| Gray Michael | CFO & COO | 27,610 | Feb 22, 2023 | 0 |
| Leonard Braden Michael | 10% Owner | 1,767,774Indirect | Jan 5, 2023 | 0 |
| Goldfischer Carl | Director | – | Jun 3, 2022 | 0 |
| Mott David M | Director | 229,224 | Jun 3, 2022 | 0 |
| Bonita David P | Director, 10% Owner | 4,199,068Indirect | Jun 3, 2022 | 0 |
| Dalton Barbara | Director | – | Jun 3, 2022 | 0 |
| Conner Edward R. | Director | – | Jun 3, 2022 | 0 |
| Chin Mark | Director | 2,344,072Indirect | Jun 3, 2022 | 0 |
| Williams Laura A | Director | – | Jun 3, 2022 | 0 |
| Kerins Patrick J | 10% Owner | 2,611,050 | Apr 7, 2022 | 0 |
| Sandell Scott D | 10% Owner | 2,611,050 | Apr 7, 2022 | 0 |
| Baskett Forest | 10% Owner | 2,611,050 | Apr 7, 2022 | 0 |
| New Enterprise Associates 14, L.P. | 10% Owner | 2,611,050 | Apr 7, 2022 | 0 |
| NEA Partners 14, L.P. | 10% Owner | 2,611,050 | Apr 7, 2022 | 0 |
| Nea 14 GP, Ltd | 10% Owner | 2,611,050 | Apr 7, 2022 | 0 |
| Sonsini Peter W. | 10% Owner | 2,611,050 | Apr 7, 2022 | 0 |
| Florence Anthony A. Jr. | 10% Owner | 2,611,050 | Apr 7, 2022 | 0 |
| Attie Kenneth | SVP, CMO | 34,100 | Feb 1, 2022 | 0 |
| OrbiMed Capital LLC | Director, 10% Owner | 1,666,666Indirect | Jul 16, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 24, 2022 (view filing)4:41 PM ET | Oct 20-24 | 4 days | RA Capital Healthcare Fund LP and 3 others10% Owner | PPurchase | +85.9K | $3.92 | +$336.8K | +2.7%3.22M after | 3 lots |
| Oct 19, 2022 (view filing)4:40 PM ET | Oct 17-19 | 2 days | RA Capital Healthcare Fund LP and 3 others10% Owner | PPurchase | +506.2K | $3.68 | +$1.86M | +19.3%3.13M after | 3 lots |
| Jun 21, 2022 (view filing) | Jun 16 | 5 days | Leonard Braden Michael10% Owner | PPurchase | +83.2K | $1.11 | +$92.4K | +2.8%3.02M after | |
| Jun 7, 2022 (view filing) | Jun 3-6 | 4 days | Leonard Braden Michael10% Owner | PPurchase | +33.4K | $1.14 | +$38.2K | +1.2%2.93M after | 2 lots |
| May 18, 2022 (view filing) | May 16-17 | 2 days | Leonard Braden Michael10% Owner | PPurchase | +41.1K | $1.23 | +$50.5K | +1.4%2.90M after | 2 lots |
| Apr 25, 2022 (view filing) | Apr 21-22 | 4 days | Leonard Braden Michael10% Owner | PPurchase | +560.0K | $1.40 | +$783.8K | +24.3%2.86M after | 2 lots |
| Apr 7, 2022 (view filing)4:54 PM ET | Apr 5-6 | 2 days | Kerins Patrick J and 7 others10% Owner | SSale | −694.6K | $1.08 | −$751.3K | −21.0%2.61M after | 2 lots |
| Feb 23, 2022 (view filing) | Feb 18-23 | 5 days | Mott David MDirector | PPurchase | +151.5K | $1.45 | +$219.7K | +194.8%229.2K after | 3 lots |
| Feb 17, 2022 (view filing) | Feb 15-17 | 2 days | Mott David MDirector | PPurchase | +45.9K | $1.19 | +$54.7K | +144.3%77.8K after | 3 lots |
| Feb 14, 2022 (view filing) | Feb 10-14 | 4 days | Mott David MDirector | PPurchase | +31.8K | $1.23 | +$39.2K | New position31.8K after | 3 lots |
| Jan 25, 2022 (view filing)8:41 PM ET | Jan 21-25 | 4 days | Kerins Patrick J and 7 others10% Owner | SSale | −134.6K | $1.50 | −$202.2K | −3.9%3.31M after | 3 lots |
| Jan 20, 2022 (view filing)5:20 PM ET | Jan 18-20 | 2 days | Kerins Patrick J and 7 others10% Owner | SSale | −26.6K | $1.83 | −$48.7K | −0.8%3.44M after | 3 lots |
| Jan 14, 2022 (view filing)5:04 PM ET | Jan 12-14 | 2 days | Kerins Patrick J and 7 others10% Owner | SSale | −21.6K | $1.94 | −$41.8K | −0.6%3.47M after | 3 lots |
| Jan 11, 2022 (view filing)5:54 PM ET | Jan 7-11 | 4 days | Kerins Patrick J and 7 others10% Owner | SSale | −18.8K | $2.07 | −$38.7K | −0.5%3.49M after | 3 lots |
| Jan 6, 2022 (view filing)5:35 PM ET | Jan 4-6 | 2 days | Kerins Patrick J and 7 others10% Owner | SSale | −31.9K | $2.26 | −$72.2K | −0.9%3.51M after | 3 lots |
| Jan 3, 2022 (view filing)8:15 PM ET | Dec 30, 2021-Jan 3, 2022 | 4 days | Kerins Patrick J and 7 others10% Owner | SSale | −116.5K | $2.29 | −$266.9K | −3.2%3.54M after | 3 lots |
| Dec 29, 2021 (view filing)6:35 PM ET | Dec 27-29 | 2 days | Florence Anthony A. Jr. and 7 othersDirector, 10% Owner | SSale | −67.4K | $2.37 | −$159.5K | −1.8%3.66M after | 3 lots |
| Dec 27, 2021 (view filing)4:34 PM ET | Dec 9-23 | 18 daysLate | Kerins Patrick J and 7 others10% Owner | SSale | −291.2K | $2.36 | −$688.5K | −7.3%3.72M after | 11 lots |
| Jul 28, 2021 (view filing) | Jul 16 | 12 daysLate | Chin MarkDirector | PPurchase | +1.33M | $6.00 | +$8.00M | +131.9%2.34M after | |
| Jul 23, 2021 (view filing)5:30 PM ET | Jul 16 | 7 days | OrbiMed Advisors LLC and 1 otherDirector, 10% Owner | PPurchase | +1.67M | $6.00 | +$10.0M | +65.8%4.20M after | AmendedDuplicate filing |
| Jul 23, 2021 (view filing) | Jul 16 | 7 days | Bonita David PDirector, 10% Owner | PPurchase | +1.67M | $6.00 | +$10.0M | +65.8%4.20M after | Amended |
| Jul 16, 2021 (view filing)4:27 PM ET | Jul 16 | Same day | OrbiMed Advisors LLC and 2 othersDirector, 10% Owner | PPurchase | +1.67M | $6.00 | +$10.0M | New position1.67M after |